| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10910953 | Lung Cancer | 2015 | 8 Pages |
Abstract
Liver metastasis predicts poorer PFS and OS in stage IV lung adenocarcinoma patients with susceptible gene mutations receiving first-line gefitinib. Further study is warranted to elucidate the underlying mechanisms and find treatment modalities to improve prognosis of these patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kuan-Li Wu, Ming-Ju Tsai, Chih-Jen Yang, Wei-An Chang, Jen-Yu Hung, Chun-Ju Yen, Chi-Hsiang Shen, Tzu-Yu Kuo, Jui-Ying Lee, Shah-Hwa Chou, Ta-Chih Liu, Inn-Wen Chong, Ming-Shyan Huang,